Daily Note 15/12/2022 – Market View: Day Ahead, Macro, Stocks, Debt Markets


  • Markets were in a wait and see mode ahead of last night’s interest rate decision from the US Federal Reserve.
  • In an incremental positive for Sanofi, Dupixent has been approved by the EC as the first and only targeted medicine indicated for prurigo nodularis, a chronic extremely itchy skin disorder. It is already approved for the condition in the US.
  • US bond yields moved marginally higher yesterday.